BIOMAT Database Logo BIOMAT Database Logo

BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. 2012

Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
Experimental Immunology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

The bromodomain protein, BRD4, has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt's lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer. BRD4 also contributes to regulation of both cell cycle and transcription of oncogenes, HIV, and human papilloma virus (HPV). Despite its role in a broad range of biological processes, the precise molecular mechanism of BRD4 function remains unknown. We report that BRD4 is an atypical kinase that binds to the carboxyl-terminal domain (CTD) of RNA polymerase II and directly phosphorylates its serine 2 (Ser2) sites both in vitro and in vivo under conditions where other CTD kinases are inactive. Phosphorylation of the CTD Ser2 is inhibited in vivo by a BRD4 inhibitor that blocks its binding to chromatin. Our finding that BRD4 is an RNA polymerase II CTD Ser2 kinase implicates it as a regulator of eukaryotic transcription.

UI MeSH Term Description Entries
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012319 RNA Polymerase II A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6. DNA-Dependent RNA Polymerase II,RNA Pol II,RNA Polymerase B,DNA Dependent RNA Polymerase II
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription

Related Publications

Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
The Medicago CDKC;1-CYCLINT;1 kinase complex phosphorylates the carboxy-terminal domain of RNA polymerase II and promotes transcription.
June 2005, The Plant journal : for cell and molecular biology,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
The RNA polymerase II carboxy-terminal domain (CTD) code.
November 2013, Chemical reviews,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
A protein kinase that phosphorylates the C-terminal repeat domain of the largest subunit of RNA polymerase II.
May 1989, Proceedings of the National Academy of Sciences of the United States of America,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II.
May 2009, Molecular cell,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
RNA polymerase II carboxy-terminal domain with multiple connections.
June 2007, Experimental & molecular medicine,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats.
June 2004, The Journal of biological chemistry,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
Phosphorylation of the RNA polymerase II carboxy-terminal domain by the Bur1 cyclin-dependent kinase.
July 2001, Molecular and cellular biology,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
The carboxy terminal domain of RNA polymerase II and alternative splicing.
September 2010, Trends in biochemical sciences,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
RNA polymerase II clustering through carboxy-terminal domain phase separation.
September 2018, Nature structural & molecular biology,
Ballachanda N Devaiah, and Brian A Lewis, and Natasha Cherman, and Michael C Hewitt, and Brian K Albrecht, and Pamela G Robey, and Keiko Ozato, and Robert J Sims, and Dinah S Singer
Decoding the informational properties of the RNA polymerase II Carboxy Terminal Domain.
May 2012, BMC research notes,
Copied contents to your clipboard!